[{"AccountsPayableCurrent_0_Q3_USD":4984000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":19000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-25000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-1893000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-181000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-181000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-1912000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-156000.0,"OtherAssetsNoncurrent_0_Q3_USD":22823000.0,"OtherAssetsCurrent_0_Q3_USD":20980000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":14053000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0771,"OperatingLeaseRightOfUseAsset_0_Q3_USD":20930000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-117000.0,"OperatingLeasePayments_3_Q3_USD":4476000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4072000.0,"OperatingLeaseLiability_0_Q3_USD":22222000.0,"OperatingLeaseCost_3_Q3_USD":4200000.0,"OperatingLeaseCost_1_Q3_USD":1400000.0,"OperatingIncomeLoss_3_Q3_USD":-446873000.0,"OperatingIncomeLoss_1_Q3_USD":-127995000.0,"OperatingExpenses_3_Q3_USD":453146000.0,"OperatingExpenses_1_Q3_USD":133645000.0,"NetIncomeLoss_3_Q3_USD":-598421000.0,"NetIncomeLoss_1_Q3_USD":-195571000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-450627000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":162636000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":18150000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":8278000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1366000.0,"PaymentsToAcquireAvailableForSaleSecurities_3_Q3_USD":171280000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2480000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":258105000.0,"StockholdersEquity_0_Q3_USD":-57325000.0,"ShareBasedCompensation_3_Q3_USD":51355000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":5675000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":6273000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5650000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1508755000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q3_USD":-362000.0,"RestrictedCashCurrent_0_Q3_USD":1563000.0,"RestrictedCash_0_Q3_USD":1563000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":1551000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":267688000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6509000.0,"ProfitLoss_3_Q3_USD":-598421000.0,"ProceedsFromStockPlans_3_Q3_USD":1698000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":12131000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":335000000.0,"PrepaidExpenseCurrent_0_Q3_USD":17374000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1084000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":87733000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":85661000.0,"MarketableSecuritiesCurrent_0_Q3_USD":146566000.0,"LiabilitiesCurrent_0_Q3_USD":94237000.0,"DeferredIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"DebtConversionConvertedInstrumentAmount1_3_Q3_USD":327276000.0,"CurrentIncomeTaxExpenseBenefit_3_Q3_USD":0.0,"CurrentIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"ConvertibleDebtNoncurrent_0_Q3_USD":189610000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-600314000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-195752000.0,"CommonStockValue_0_Q3_USD":9000.0,"CommonStockSharesOutstanding_0_Q3_shares":87219000.0,"CommonStockSharesIssued_0_Q3_shares":87219000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":0.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":285308000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":283745000.0,"AssetsCurrent_0_Q3_USD":475427000.0,"Assets_0_Q3_USD":525689000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":18909000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":18909000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":17194000.0,"AdditionalPaidInCapital_0_Q3_USD":1453431000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-2010000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":69847000.0,"AccountsReceivableNetCurrent_0_Q3_USD":3522000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-281737000.0,"LitigationSettlementAmountAwardedToOtherParty_3_Q3_USD":0.0,"Depreciation_3_Q3_USD":1006000.0,"DerivativeGainLossOnDerivativeNet_3_Q3_USD":-42483000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":525689000.0,"Liabilities_0_Q3_USD":583014000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":4523000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1436000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":5625000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":4862000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":5561000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":26745000.0,"InvestmentIncomeNonoperating_3_Q3_USD":381000.0,"InvestmentIncomeNonoperating_1_Q3_USD":144000.0,"InventoryWorkInProcess_0_Q3_USD":1400000.0,"InventoryNet_0_Q3_USD":1677000.0,"DerivativeGainLossOnDerivativeNet_1_Q3_USD":-4219000.0,"InventoryFinishedGoods_0_Q3_USD":300000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":5862000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":3956000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":-6677000.0,"IncreaseDecreaseInInventories_3_Q3_USD":1677000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-42092000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2618000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-3213000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":135309000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":45763000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-2024000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-7.31,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-2.28,"InterestPaidNet_3_Q3_USD":10265000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":81846000.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]